N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. حسب Noelia Carballeda-Sangiao (2889611)

TXNIP loss does not increase chromatin accessibility. حسب Tian-Yeh Lim (14808976)

JNJ26993135 + BML-111 decreases permeability and enhances ZO-1 and claudin-1 induced by PAF but does not change TEER. حسب Kameljit K. Kalsi (16496511)

Transepithelial electrical resistance (TEER) (N = 6). حسب Shirko Marcel Shokr (19173337)

"…<p><b>(A)</b> During the cultivation of SMC and ALI we observed significantly differences on day 18 (SMC: 9.61 kΩ*cm²; ALI: 7.73 kΩ*cm²; p<0.05) and day 25 (SMC: 8.19 kΩ*cm²; ALI: 6.44 kΩ*cm²; p<0.05) ALI cultures showed significantly decreased values compared to SMC. …"

PTEN KD increases chromatin accessibility. حسب Ahmed H. Ghobashi (12705573)

"…Red dots indicate peaks with significantly increased or decreased accessibility with Log2 FC > |0.5|. …"

LIF knockout reduces increases immune accessibility. حسب Priyan Bhattacharya (11986545)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. حسب Ellie S. Burns (21246537)

Pathway analysis based on the protein accessions from the significant glycopeptiforms separately for glycation and glycosylation. حسب Yishai Levin (702481)

Accessible data. حسب Neda Mohammadisima (17199999)

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... حسب Mingee Choi (15250732)

الموضوعات:

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). حسب Mingee Choi (15250732)

الموضوعات:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. حسب Mingee Choi (15250732)

الموضوعات:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. حسب Mingee Choi (15250732)

الموضوعات:

General information of patient who diagnosis insomnia disorder (N = 518,119). حسب Mingee Choi (15250732)

الموضوعات:

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. حسب Mingee Choi (15250732)

الموضوعات:

Treatment at first diagnosis of insomnia disorder (%). حسب Mingee Choi (15250732)

الموضوعات:

PTEN KD increases chromatin accessibility at EMT genes. حسب Ahmed H. Ghobashi (12705573)

ATRX knockdown increases the accessibility of infecting HCMV genomes. حسب Ryan M. Walter (19550606)

Global ownership, access and use gap. حسب Gountante Kombate (6942611)

الموضوعات:

Duration of blood pressure decrease. حسب Ai Wei (120010)